Parachute
AI NativeInfrastructure for hospitals to deploy and monitor clinical AI
Est 2025|Raised $500K
Infrastructure for hospitals to deploy and monitor clinical AI
Published Aug 14, 2026
No public market share figures were found specifically for Parachute. Current public adoption evidence is primarily accelerator affiliation and vendor-claimed references.
| Starting Price | Not public (demo/quote) | Not public (demo/quote) | Not public (demo/quote) |
| Recommended For | Hospitals needing end-to-end clinical AI governance, monitoring, and audit trails | Health systems seeking governance with healthcare-oriented security posture and EHR integrations | Large enterprises needing broad AI governance across business units and AI types |
| Key Strength | Hospital-specific framing: vendor vetting → evaluation → monitoring → audit trail (vendor positioning) | Healthcare-security positioning (HIPAA/SOC2 messaging; EHR integration focus) | Broad enterprise AI governance tooling with lifecycle coverage |
| Key Weakness | Limited public security documentation and limited independent reviews (early stage) | Needs buyer validation on fit for specific clinical AI categories; pricing unclear | May require tailoring for clinical AI governance and healthcare regulatory nuance |
—
Parachute is positioned around the clinical AI lifecycle and addressing prolonged pilot phases. Healthcare buyers typically prioritize compliance posture (HIPAA, SOC 2 Type II, BAA readiness) and integration ease. Some competitors explicitly present these controls on their sites.
Harness.health presents a healthcare-focused security and integration posture, including HIPAA and SOC 2 messaging and EHR integration claims.
Parachute compared with broad enterprise AI governance platforms: